3 Stocks Near 52-Week Lows Worth Buying
Do these fallen angels deserve a second chance? You be the judge!
Here's What Super-Investor Seth Klarman Has Been Buying
It can be smart to keep an eye on the smart investors out there.
Enzon Pharmaceuticals Considers Sale of Assets, Company
Review will analyze selling parts or entirety of company